|
Real-time Estimate
Cboe BZX
18:12:19 29/09/2026 +04
|
5-day change | 1st Jan Change | ||
| 0.9560 USD | -1.54% |
|
-8.62% | -43.09% |
| 08-07 | Lineage Cell Therapeutics, Inc., Q2 2026 Earnings Call, Aug 06, 2026 | |
| 08-07 | Lineage Cell Therapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
Stock exchange
NYSE
LCTX 0.9601 $
-1.12%
143K
$
| Markets | Price | Change | Volumes | ||
|---|---|---|---|---|---|
| LCTX | 0.9601USD | -1.12% | 143K $ | ||
CBOE
| LCTX | 0.9563USD | -0.64% | 6.13K $ | |
|
Tradegate
| BT3 | 0.8500EUR | -6.39% | 1.69K € | |
|
Boerse Muenchen
| BT3 | 0.8610EUR | -1.26% | 430.5 € | |
|
TEL AVIV STOCK EXCHANGE
| LCTX | 300.60ILa | 0.00% | 12.32K ILa | |
|
Deutsche Boerse AG
| BT3 | 0.8280EUR | -5.37% | 0 € | |
|
Börse Stuttgart
| BT3 | 0.8560EUR | +1.78% | 0 € |
Quotes 5-day view: Lineage Cell Therapeutics, Inc.
Delayed Quote NYSE
| 23/09/2026 | 24/09/2026 | 25/09/2026 | 28/09/2026 | 29/09/2026 | |
|---|---|---|---|---|---|
| Last | $0.9567 | $0.9478 | $1.030 | $0.9710 | $0.9601 |
| Volume | 2,630,848 | 2,439,912 | 2,481,540 | 1,574,173 | 148,788 |
| Change | -8.01% | -0.93% | +8.67% | -5.73% | -1.54% |
| Opening | $1.020 | $0.9519 | $0.9500 | $1.020 | $0.9800 |
| High | $1.040 | $0.9692 | $1.040 | $1.040 | $0.9900 |
| Low | $0.9551 | $0.9101 | $0.9419 | $0.9600 | $0.9500 |
Performance
| 1 day | -1.54% | ||
| 1 week | -8.62% | ||
| Current month | -13.60% | ||
| 1 month | -13.60% | ||
| 3 months | -29.60% | ||
| 6 months | -35.35% | ||
| Current year | -43.09% | ||
| 1 year | -46.91% | ||
| 3 years | -19.46% | ||
| 5 years | -62.58% | ||
| 10 years | -74.10% |
Volumes
marketsDaily volume
148,788
Estimated daily volume
2,045,616
Avg. Volume 20 sessions
1,636,335
Daily volume ratio
1.25
Avg. Volume 20 sessions USD
1,564,336.26
Record volume 1
23,661,485
Record volume 2
22,539,712
Record volume 3
17,430,494
Capital turnover ratio
0.01
Float rotation
0.01
Basic data
Market Cap (USD)
245,573,147
Net sales (USD)
14,556,000
Number of employees
75
Sales / Employee (USD)
194,080
Free-Float
95.14%
Free-Float capitalization (USD)
233,638,253
Average Daily Capital Traded
0.64%
Indicators
Moving average 5 days
0.9891
Moving average 20 days
1.049
Moving average 50 days
1.078
Moving average 100 days
1.172
Price spread / (MMA5)
+3.46%
Price spread / (MMA20)
+9.70%
Price spread / (MMA50)
+12.75%
Price spread / (MMA100)
+22.65%
STIM
RSI 9 days
49.28
RSI 14 days
47.04
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.54% | -8.62% | -46.91% | -19.46% | 246M | |
| -0.27% | +3.55% | +12.12% | +36.94% | 49.06B | |
| -0.63% | -0.19% | +49.16% | +37.01% | 44.6B | |
| -0.14% | +4.65% | +338.11% | +629.17% | 43.24B | |
| -1.94% | -1.87% | +8.52% | +100.81% | 41.73B | |
| +0.51% | -1.71% | +5.18% | +46.87% | 29.93B | |
| +0.19% | -1.98% | +23.35% | +155.11% | 17.19B | |
| -0.38% | +11.54% | +9.58% | - | 15.35B | |
| -2.21% | -2.51% | +26.61% | +43.89% | 15.54B | |
| -1.82% | -4.92% | - | - | 15.11B | |
| Average | -0.90% | +1.28% | +47.30% | +128.79% | 27.2B | |
| Weighted average by Cap. | -0.77% | +2.25% | +73.45% | +164.04% |
Historical Quotes: Lineage Cell Therapeutics, Inc.
| Date | Opening | High | Low | Close | Volume | Change |
|---|
Latest transactions
cd7c9.RCu0JgVnCr6fRerGwyeGo6zQfTvQTAKZJcYIq-GQa-E.Elr5fk9WZ_OsKL-Zlgrn5v67HAyYekTvFJdlm8ymCpgXEtd1bhVLxtENhQ
| Date | Price | Volume | Total |
|---|---|---|---|
| 17:58:18 | 0.9601 | 100 | 144,395 |
| 17:58:02 | 0.9601 | 200 | 144,295 |
| 17:57:55 | 0.9601 | 100 | 144,095 |
| 17:57:54 | 0.9601 | 300 | 143,995 |
| 17:57:34 | 0.9562 | 100 | 143,695 |
| 17:57:34 | 0.9505 | 100 | 143,595 |
| 17:57:32 | 0.9557 | 122 | 143,495 |
| 17:57:24 | 0.9562 | 100 | 143,373 |
| 17:57:24 | 0.9562 | 100 | 143,273 |
| 17:57:10 | 0.9504 | 100 | 143,173 |
Price Extremes
| 1 week | 0.91 |  | 1.04 |
| 1 month | 0.91 | | 1.16 |
| Current year | 0.91 | | 1.98 |
| 1 year | 0.91 | | 2.09 |
| 3 years | 0.37 | | 2.09 |
| 5 years | 0.37 | | 2.71 |
| 10 years | 0.37 | | 3.97 |
Monthly variations
Annual variations
| 2026 | -41.86% | ||
| 2025 | +232.34% | ||
| 2024 | -53.90% | ||
| 2023 | -6.84% | ||
| 2022 | -52.24% | ||
| 2021 | +39.20% | ||
| 2020 | +97.75% | ||
| 2019 | -2.52% | ||
| 2018 | -57.53% | ||
| 2017 | -40.44% | ||
| 2016 | -11.95% | ||
| 2015 | +9.92% | ||
| 2014 | +3.61% | ||
| 2013 | +14.65% | ||
| 2012 | -45.96% | ||
| 2011 | -30.25% | ||
| 2010 | +96.93% | ||
| 2009 | +138.98% | ||
| 2008 | +331.71% | ||
| 2007 | +54.72% | ||
| 2006 | -14.52% | ||
| 2005 | -79.47% | ||
| 2004 | +9.42% | ||
| 2003 | -10.97% | ||
| 2002 | -66.30% | ||
| 2001 | -38.67% | ||
| 2000 | -15.49% | ||
| 1999 | -48.92% | ||
| 1998 | -8.55% | ||
| 1997 | +103.57% | ||
| 1996 | +796.00% | ||
| 1995 | +56.25% | ||
| 1994 | -74.60% | ||
| 1993 | -19.23% | ||
| 1992 | -4.88% |
- Stock Market
- Stocks
- LCTX Stock
- Quotes Lineage Cell Therapeutics, Inc.
Select your edition
All financial news and data tailored to specific country editions
